Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest VR Adviser, LLC Stock Portfolio

$2.10Billion– No. of Holdings #38

VR Adviser, LLC Performance:
2024 Q1: 22.64%YTD: 22.64%2023: 5.43%

Performance for 2024 Q1 is 22.64%, and YTD is 22.64%, and 2023 is 5.43%.

About VR Adviser, LLC and 13F Hedge Fund Stock Holdings

VR Adviser, LLC is a hedge fund based in NEW YORK, NY. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $2.4 Billions. In it's latest 13F Holdings report, VR Adviser, LLC reported an equity portfolio of $2.1 Billions as of 31 Mar, 2024.

The top stock holdings of VR Adviser, LLC are , FDMT, OCUL. The fund has invested 26.9% of it's portfolio in APOGEE THERAPEUTICS INC and 6.7% of portfolio in 4D MOLECULAR THERAPEUTICS IN.

The fund managers got completely rid off RAYZEBIO INC, AMBRX BIOPHARMA INC (AMAM) and RHYTHM PHARMACEUTICALS INC (RYTM) stocks. They significantly reduced their stock positions in CELCUITY INC (CELC), CABALETTA BIO INC (CABA) and TERNS PHARMACEUTICALS INC (TERN). VR Adviser, LLC opened new stock positions in ENGENE HOLDINGS INC, EDGEWISE THERAPEUTICS INC (EWTX) and AQUESTIVE THERAPEUTICS INC (AQST). The fund showed a lot of confidence in some stocks as they added substantially to DIANTHUS THERAPEUTICS INC, PRAXIS PRECISION MEDICINES I (PRAX) and ORIC PHARMACEUTICALS INC (ORIC).
VR Adviser, LLC Equity Portfolio Value
Last Reported on: 15 May, 2024

VR Adviser, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that VR Adviser, LLC made a return of 22.64% in the last quarter. In trailing 12 months, it's portfolio return was 40.26%.

New Buys

Ticker$ Bought
engene holdings inc43,491,000
edgewise therapeutics inc33,163,600
aquestive therapeutics inc23,666,700
adverum biotechnologies inc22,007,800
immatics n.v18,392,500
cg oncology inc15,365,000
century therapeutics inc14,233,500
tenaya therapeutics inc8,135,560

New stocks bought by VR Adviser, LLC

Additions

Ticker% Inc.
dianthus therapeutics inc125
praxis precision medicines i99.68
oric pharmaceuticals inc80.97
ocular therapeutix inc64.13
kalvista pharmaceuticals inc52.7
applied therapeutics inc45.2
enliven therapeutics inc36.26
abivax sa34.77

Additions to existing portfolio by VR Adviser, LLC

Reductions

Ticker% Reduced
celcuity inc-48.56
cabaletta bio inc-39.00
terns pharmaceuticals inc-24.17
merus n v-16.67
taysha gene therapies inc-13.57
spyre therapeutics inc-8.47

VR Adviser, LLC reduced stake in above stock

Sold off

Ticker$ Sold
rayzebio inc-250,574,000
savara inc-16,450,000
ambrx biopharma inc-29,476,800
gh research plc-7,646,300
milestone pharmaceuticals in-1,544,830
adverum biotechnologies inc-3,875,070
rhythm pharmaceuticals inc-22,800,300

VR Adviser, LLC got rid off the above stocks

Sector Distribution

VR Adviser, LLC has about 57.8% of it's holdings in Healthcare sector.

Sector%
Healthcare57.8
Others42.2

Market Cap. Distribution

VR Adviser, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP43.2
UNALLOCATED42.2
MID-CAP8
MICRO-CAP5.8

Stocks belong to which Index?

About 40.9% of the stocks held by VR Adviser, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others59.1
RUSSELL 200040.9
Top 5 Winners (%)%
TRVI
trevi therapeutics inc
157.4 %
DYN
dyne therapeutics inc
113.5 %
MRSN
mersana therapeutics inc
93.1 %
PRAX
praxis precision medicines i
85.3 %
APLT
applied therapeutics inc
70.8 %
Top 5 Winners ($)$
FDMT
4d molecular therapeutics in
44.2 M
OCUL
ocular therapeutix inc
43.7 M
MRUS
merus n v
37.3 M
AGLE
spyre therapeutics inc
36.0 M
DYN
dyne therapeutics inc
32.8 M
Top 5 Losers (%)%
VRDN
viridian therapeutics inc
-19.6 %
OLMA
olema pharmaceuticals inc
-19.3 %
CABA
cabaletta bio inc
-15.9 %
ADVM
adverum biotechnologies inc
-12.0 %
EYPT
eyepoint pharmaceuticals inc
-10.6 %
Top 5 Losers ($)$
VRDN
viridian therapeutics inc
-16.6 M
CABA
cabaletta bio inc
-9.2 M
KALV
kalvista pharmaceuticals inc
-4.9 M
ADVM
adverum biotechnologies inc
-3.0 M
EYPT
eyepoint pharmaceuticals inc
-0.6 M

VR Adviser, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of VR Adviser, LLC

VR Adviser, LLC has 38 stocks in it's portfolio. About 63.6% of the portfolio is in top 10 stocks. VRDN proved to be the most loss making stock for the portfolio. FDMT was the most profitable stock for VR Adviser, LLC last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions